The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 08, 2020
Filed:
Jun. 03, 2016
Applicant:
Glaxosmithkline Intellectual Property Development Limited, Brentford, Middlesex, GB;
Inventors:
Christopher W. Cluff, Hamilton, MT (US);
Hua-Xin Gao, Collegeville, PA (US);
Assignee:
GlaxoSmithKline Intellectual Property Development Limited, Brentford, Middlesex, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7032 (2006.01); A61P 35/00 (2006.01); A61K 31/407 (2006.01); A61K 45/06 (2006.01); A61K 31/675 (2006.01); A61K 9/00 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7032 (2013.01); A61K 9/0019 (2013.01); A61K 31/407 (2013.01); A61K 31/675 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07K 16/2818 (2013.01); A61K 2039/505 (2013.01);
Abstract
Disclosed is a TLR4 agonist alone or in combination with an anti-cancer agent and pharmaceutical compositions thereof, uses thereof, and methods of treatment comprising administering said composition or combination, including uses in cancer.